Deferiprone versus desferrioxamine in thalassaemia, and T2*validation and utility - Reply

被引：15

作者：

Kontoghiorghes, GJ ^{[1
]}

Kolnagou, A ^{[1
]}

机构：

[1] Postgrad Res Inst Sci Technol Environm & Med, Limassoi 3021, Cyprus

来源：

LANCET | 2003年 / 361卷 / 9352期

关键词：

D O I：

10.1016/S0140-6736(03)12225-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：184 / 184

页数：1

共 5 条

[1] Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia [J].

Anderson, LJ ;

Wonke, B ;

Prescott, E ;

Holden, S ;

Walker, JM ;

Pennell, DJ .

LANCET, 2002, 360 (9332) :516-520

[2] Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1) [J].

Kontoghiorghes, GJ ;

Pattichi, K ;

Hadjigavriel, M ;

Kolnagou, A .

TRANSFUSION SCIENCE, 2000, 23 (03) :211-223

[3] Deferiprone versus deferoxamine in patients with thalassemia major: A randomized clinical trial [J].

Maggio, A ;

D'Amico, G ;

Morabito, A ;

Capra, M ;

Ciaccio, C ;

Cianciulli, P ;

Di Gregorio, F ;

Garozzo, G ;

Malizia, R ;

Magnano, C ;

Mangiagli, A ;

Quarta, G ;

Rizzo, M ;

D'Ascola, DG ;

Rizzo, A ;

Midiri, M .

BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (02) :196-208

[4]

MARCUS RE, 1984, LANCET, V1, P392

[5] STUDIES IN DESFERRIOXAMINE AND FERRIOXAMINE METABOLISM IN NORMAL AND IRON-LOADED SUBJECTS [J].

SUMMERS, MR ;

JACOBS, A ;

TUDWAY, D ;

PERERA, P ;

RICKETTS, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (04) :547-555

← 1 →